Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.690
-0.070 (-1.86%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Apyx Medical stock have an average target of 6.50, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 76.15% from the current stock price of 3.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 11, 2026.
Analyst Ratings
The average analyst rating for Apyx Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +62.60% | Mar 11, 2026 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $6 | Hold → Strong Buy | Upgrades | $6 | +62.60% | Mar 11, 2026 |
| Roth Capital | Roth Capital | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +62.60% | Dec 16, 2025 |
| Citizens | Citizens | Hold → Buy Upgrades $8 | Hold → Buy | Upgrades | $8 | +116.80% | Nov 12, 2025 |
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
Financial Forecast
Revenue This Year
59.15M
from 52.84M
Increased by 11.93%
Revenue Next Year
65.66M
from 59.15M
Increased by 11.01%
EPS This Year
-0.32
from -0.27
EPS Next Year
-0.28
from -0.32
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 61.2M | 69.3M | |||
| Avg | 59.1M | 65.7M | |||
| Low | 56.4M | 60.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.8% | 17.2% | |||
| Avg | 11.9% | 11.0% | |||
| Low | 6.8% | 2.4% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.32 | -0.21 |
| Avg | -0.32 | -0.28 |
| Low | -0.34 | -0.35 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.